ArticleNature communications2025

The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis.

Andreas Römpp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.